Home Hemodialysis

  • Brent W. MillerEmail author


With the advent of newer technology and the increasing cost structure of center-based hemodialysis therapy, home hemodialysis is likely to become more prevalent. Thus, the physician managing vascular access will need to be cognizant of the specifics of hemodialysis at home. This chapter will focus on the differences between center-based dialysis and home hemodialysis and discuss self-cannulation principles and ergonomics, changes in dialysis frequency and length, and clinical monitoring of the access from a remote location.


Home hemodialysis 


  1. 1.
    Blagg CR, et al. Home hemodialysis: six years’ experience. N Engl J Med. 1970;283:1126–31.CrossRefPubMedGoogle Scholar
  2. 2.
    Eggers PW. Medicare’s end stage renal disease program. Health Care Financ Rev. 2000;22:55–60.PubMedPubMedCentralGoogle Scholar
  3. 3.
    United States Food and Drug Administration 510(k) summary K070049. 3 Feb 2011.
  4. 4.
    United States Food and Drug Administration 510(k) summary K050525. 24 June 2005.
  5. 5.
    Ahmad S. Essentials of water treatment in hemodialysis. Hemodial Int. 2005;9:127–34.CrossRefPubMedGoogle Scholar
  6. 6.
    Association for the Advancement of Medical Instrumentation. Water for hemodialysis and related therapies ANSI/AAMI 13959/2014. Arlington: Association for the Advancement of Medical Instrumentation; 2014.Google Scholar
  7. 7.
    Dalal S, et al. L-lactate high efficiency hemodialysis: hemodynamics, blood gas changes, potassium/phosphorus and symptoms. Kidney Int. 1990;38:896–903.CrossRefPubMedGoogle Scholar
  8. 8.
    Lok CE, et al. Frequent hemodialysis fistula infectious complications. Nephron Extra. 2014;4:159–63.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    MacRae JM, et al. Arteriovenous fistula survival and needling technique: long-term results from a randomized buttonhole trial. Am J Kidney Dis. 2014;63:636–42.CrossRefPubMedGoogle Scholar
  10. 10.
    Nesrallah GE, et al. Staphylococcus aureus bacteremia and buttonhole cannulation: long-term safety and efficacy of mupirocin prophylaxis. Clin J Am Soc Nephrol. 2010;5:1047–53.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Wong B, et al. Procedure-related serious adverse events among home hemodialysis patients: a quality assurance perspective. Am J Kidney Dis. 2014;63:251–8.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2017

Authors and Affiliations

  1. 1.Division of NephrologyWashington UniversitySaint LouisUSA

Personalised recommendations